Legislation is pending, House Bill 2152, to permit qualified patients access to marijuana or extracts containing CBD and low levels of THC.
The measure would permit patients with Alzheimer’s disease, cancer, multiple sclerosis, post-traumatic stress disorder or a condition causing seizures, including those characteristic of epilepsy, to possess marijuana or extracts containing no more than three percent THC. The measure also seeks to establish rules governing the state-licensed cultivation of low-THC marijuana strains and the preparation of products derived from such strains.
While HB 2152 does not legalize medical marijuana outright, it is an important first step in the process of revisiting and revising Kansas’ marijuana laws.
You can write your lawmakers in support of this penalty reduction by entering your information below.